Rajeev Varshney Selected Research

6-Aminonicotinamide (6 Aminonicotinamide)

10/2012	Radiosensitization by 2-deoxy-D-glucose and 6-aminonicotinamide involves activation of redox sensitive ASK1-JNK/p38MAPK signaling in head and neck cancer cells.
8/2012	A combination of 2-deoxy-D-glucose and 6-aminonicotinamide induces cell cycle arrest and apoptosis selectively in irradiated human malignant cells.
10/2011	A combination of 2-deoxy-D-glucose and 6-aminonicotinamide induces oxidative stress mediated selective radiosensitization of malignant cells via mitochondrial dysfunction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rajeev Varshney Research Topics

Disease

4	Infections 05/2022 - 09/2021
4	Neoplasms (Cancer) 01/2022 - 08/2010
3	COVID-19 05/2022 - 09/2021
3	Hypoxia (Hypoxemia) 01/2022 - 01/2021
3	Mitochondrial Diseases (Mitochondrial Disease) 08/2012 - 06/2011
2	Head and Neck Neoplasms (Head and Neck Cancer) 10/2012 - 06/2011
1	Ischemia 11/2022
1	Cold Injury 11/2022
1	Thrombosis (Thrombus) 11/2022
1	Necrosis 11/2022
1	Coronavirus Infections 05/2022
1	Severe Acute Respiratory Syndrome 05/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Dyslipidemias (Dyslipidemia) 01/2021
1	Pulmonary Edema 01/2021
1	Inflammation (Inflammations) 01/2021
1	Glioma (Gliomas) 08/2010
1	Hyperthyroidism 01/2006

Drug/Important Bio-Agent (IBA)

3	6-Aminonicotinamide (6 Aminonicotinamide)IBA 10/2012 - 10/2011
3	Deoxyglucose (2 Deoxy D glucose)IBA 10/2012 - 10/2011
2	LipidsIBA 11/2022 - 01/2021
2	Pharmaceutical PreparationsIBA 05/2022 - 06/2011
2	Mitochondrial DNA (mtDNA)IBA 01/2021 - 08/2010
2	AntioxidantsIBA 08/2012 - 06/2011
2	LigandsIBA 06/2011 - 08/2010
2	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2011 - 08/2010
2	bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA 06/2011 - 08/2010
1	Poloxamer (Poloxamer 407)IBA 11/2022
1	PolymersIBA 11/2022
1	IceIBA 11/2022
1	QuercetinIBA 05/2022
1	Cysteine (L-Cysteine)FDA Link 05/2022
1	AflatoxinsIBA 04/2022
1	Protein SIBA 03/2022
1	fibrin fragment D (D-dimer)IBA 03/2022
1	Fibrinogen (Factor I)FDA Link 03/2022
1	AnticoagulantsIBA 03/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	CTLA-4 AntigenIBA 01/2022
1	ABO Blood-Group SystemIBA 09/2021
1	SolutionsIBA 09/2021
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021
1	oxidized low density lipoproteinIBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	CytokinesIBA 01/2021
1	CholesterolIBA 01/2021
1	Carbonic Anhydrases (Carbonic Anhydrase)IBA 01/2021
1	Apolipoproteins E (ApoE)IBA 01/2021
1	Apolipoproteins B (ApoB)IBA 01/2021
1	ApolipoproteinsIBA 01/2021
1	HDL LipoproteinsIBA 01/2021
1	Triglycerides (Triacylglycerol)IBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 10/2012
1	DNA (Deoxyribonucleic Acid)IBA 06/2011
1	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 06/2011
1	EnzymesIBA 06/2011
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 06/2011
1	Radiation-Sensitizing AgentsIBA 08/2010
1	A-Form DNA (A-DNA)IBA 08/2010
1	Thyroid HormonesIBA 01/2006
1	Hormones (Hormone)IBA 01/2006

Therapy/Procedure

2	Therapeutics 11/2022 - 05/2022
1	Surgical Amputation (Amputations) 11/2022
1	Radiotherapy 10/2012